195 related articles for article (PubMed ID: 10482689)
41. Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis.
Wrone-Smith T; Izban KF; Ergin M; Cosar EF; Hsi ED; Alkan S
Exp Hematol; 2001 May; 29(5):572-81. PubMed ID: 11376869
[TBL] [Abstract][Full Text] [Related]
42. Fas antigen (CD95) in pure erythroid cell line AS-E2 is induced by interferon-gamma and tumor necrosis factor-alpha and potentiates apoptotic death.
Tsushima H; Imaizumi Y; Imanishi D; Fuchigami K; Tomonaga M
Exp Hematol; 1999 Mar; 27(3):433-40. PubMed ID: 10089905
[TBL] [Abstract][Full Text] [Related]
43. Secondary apoptosis of spiral ganglion cells induced by aminoglycoside: Fas-Fas ligand signaling pathway.
Bae WY; Kim LS; Hur DY; Jeong SW; Kim JR
Laryngoscope; 2008 Sep; 118(9):1659-68. PubMed ID: 18758324
[TBL] [Abstract][Full Text] [Related]
44. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
Shimizu M; Fontana A; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
J Immunol; 1999 Jun; 162(12):7350-7. PubMed ID: 10358186
[TBL] [Abstract][Full Text] [Related]
45. Apoptosis in proliferative vitreoretinopathy.
El Ghrably I; Powe DG; Orr G; Fischer D; McIntosh R; Dua HS; Tighe PJ
Invest Ophthalmol Vis Sci; 2004 May; 45(5):1473-9. PubMed ID: 15111604
[TBL] [Abstract][Full Text] [Related]
46. CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout mice.
Behrens CK; Igney FH; Arnold B; Möller P; Krammer PH
J Immunol; 2001 Mar; 166(5):3240-7. PubMed ID: 11207278
[TBL] [Abstract][Full Text] [Related]
47. Expression of Fas and Fas ligand in normal and ischemia-reperfusion testes: involvement of the Fas system in the induction of germ cell apoptosis in the damaged mouse testis.
Koji T; Hishikawa Y; Ando H; Nakanishi Y; Kobayashi N
Biol Reprod; 2001 Mar; 64(3):946-54. PubMed ID: 11207212
[TBL] [Abstract][Full Text] [Related]
48. Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells.
Aschkenazi S; Straszewski S; Verwer KM; Foellmer H; Rutherford T; Mor G
Biol Reprod; 2002 Jun; 66(6):1853-61. PubMed ID: 12021072
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of lens epithelial cells by Fas-specific antibody activating Fas-Fas ligand system.
Nishi O; Nishi K; Wada K; Ohmoto Y; Akura J
Curr Eye Res; 2001 Sep; 23(3):192-8. PubMed ID: 11803481
[TBL] [Abstract][Full Text] [Related]
50. Effects of Chinese Jianpi herbs on cell apoptosis and related gene expression in human gastric cancer grafted onto nude mice.
Zhao AG; Zhao HL; Jin XJ; Yang JK; Tang LD
World J Gastroenterol; 2002 Oct; 8(5):792-6. PubMed ID: 12378617
[TBL] [Abstract][Full Text] [Related]
51. Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis.
Xerri L; Devilard E; Hassoun J; Haddad P; Birg F
Leukemia; 1997 Nov; 11(11):1868-77. PubMed ID: 9369420
[TBL] [Abstract][Full Text] [Related]
52. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.
Bennett MW; O'connell J; O'sullivan GC; Roche D; Brady C; Kelly J; Collins JK; Shanahan F
Gut; 1999 Feb; 44(2):156-62. PubMed ID: 9895372
[TBL] [Abstract][Full Text] [Related]
53. [Effect of fas gene transfection on tumourigenicity and proliferation of transplanted tumor of oral squamous cell carcinoma cell line Tca8113].
Hou JS; Huang HZ; Wang JG; Pan CB
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Jun; 22(3):189-91. PubMed ID: 15293460
[TBL] [Abstract][Full Text] [Related]
54. Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia.
Kitagawa M; Yamaguchi S; Takahashi M; Tanizawa T; Hirokawa K; Kamiyama R
Leukemia; 1998 Apr; 12(4):486-92. PubMed ID: 9557605
[TBL] [Abstract][Full Text] [Related]
55. Vulnerability of mouse cortical neurons to doxorubicin-induced apoptosis is strain-dependent and is correlated with mRNAs encoding Fas, Fas-Ligand, and metalloproteinases.
Wetzel M; Tibbitts J; Rosenberg GA; Cunningham LA
Apoptosis; 2004 Sep; 9(5):649-56. PubMed ID: 15314293
[TBL] [Abstract][Full Text] [Related]
56. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
[TBL] [Abstract][Full Text] [Related]
57. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
58. Increased retinal neovascularization in Fas ligand-deficient mice.
Davies MH; Eubanks JP; Powers MR
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3202-10. PubMed ID: 12824272
[TBL] [Abstract][Full Text] [Related]
59. Relationship between Fas-ligand expression on carcinoma cell and cytotoxic T-lymphocyte response in lymphoepithelioma-like cancer of the stomach.
Kume T; Oshima K; Yamashita Y; Shirakusa T; Kikuchi M
Int J Cancer; 1999 Aug; 84(4):339-43. PubMed ID: 10404082
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of Fas-ligand by neuroblastoma: a novel mechanism of tumor-cell killing.
Takamizawa S; Okamoto S; Wen J; Bishop W; Kimura K; Sandler A
J Pediatr Surg; 2000 Feb; 35(2):375-9. PubMed ID: 10693700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
